whitepaper

Whitepaper: The impact of COVID-19 on neurological systems

Posted: 13 October 2020 | | No comments yet

Neurological symptoms have been observed in COVID-19 patients. The link between SARS-CoV-2 and the CNS is critical to developing effective treatments

Neurological symptoms including neuroinflammation, encephalopathy, acute necrotizing (hemorrhagic) encephalopathy (ANE), and ischemic stroke have been observed in COVID-19 patients. Even individuals who are mostly asymptomatic have experienced a loss or attenuation of smell and taste, indicative of a peripheral nervous system (PNS) effect.  Understanding the link between SARS-CoV-2 and the CNS is critical to developing effective treatments. 

READ MORE

Related organisations

Send this to a friend